Edition:
United Kingdom

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

173.42USD
22 Jun 2018
Change (% chg)

$0.93 (+0.54%)
Prev Close
$172.49
Open
$173.83
Day's High
$174.42
Day's Low
$172.26
Volume
715,263
Avg. Vol
756,010
52-wk High
$256.78
52-wk Low
$142.83

Select another date:

Thu, Jun 14 2018

Photo

Allergan appoints former Abbott executive to its board

Allergan Plc said on Thursday former Abbott Laboratories executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker's acquisition strategy and board composition.

Allergan appoints former Abbott executive to its board

June 14 Allergan Plc said on Thursday former Abbott Laboratories executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker's acquisition strategy and board composition.

Icahn buys small stake in drugmaker Allergan: sources

Billionaire investor Carl Icahn has acquired a small stake in Allergan Plc at a time when the drugmaker is under pressure from other activist shareholders, people familiar with the matter said on Wednesday.

Icahn buys small stake in drugmaker Allergan -sources

June 6 Billionaire investor Carl Icahn has acquired a small stake in Allergan Plc at a time when the drugmaker is under pressure from other activist shareholders, people familiar with the matter said on Wednesday.

Two Allergan shareholders call for split of chairman-CEO role

Two of Allergan Plc's shareholders, hedge funds Appaloosa Management and Senator Investment Group, asked the drugmaker's board to split the role of chief executive officer and chairman as well as reconsider its acquisition strategy.

UPDATE 2-Two Allergan shareholders call for split of chairman-CEO role

June 5 Two of Allergan Plc's shareholders, hedge funds Appaloosa Management and Senator Investment Group, asked the drugmaker's board to split the role of chief executive officer and chairman as well as reconsider its acquisition strategy.

Hedge fund Appaloosa asks Allergan to split chairman-CEO position

June 5 Billionaire investor David Tepper's hedge fund Appaloosa Management and Senator Investment Group on Tuesday asked Allergan Plc's board to split the office of the chief executive officer and chairman.

Allergan to sell women's health, infectious disease units

NEW YORK Drugmaker Allergan Plc said on Wednesday it plans to sell two of its smaller businesses, the women's health and infectious disease units, as Chief Executive Brent Saunders works to end a steep slide in its share price over the last year.

UPDATE 1-Allergan to sell women's health, infectious disease units

NEW YORK, May 30 Drugmaker Allergan Plc said on Wednesday it plans to sell two of its smaller businesses, the women's health and infectious disease units, as Chief Executive Brent Saunders works to end a steep slide in its share price over the last year.

Allergan plans sales of women's health, infectious disease units

NEW YORK, May 30 Drugmaker Allergan Plc plans to sell off its women's health and infectious disease businesses as Chief Executive Brent Saunders works to end the steep slide in its share price over the last year.

Select another date: